Photodynamic Inactivation Enhances Antibiotic Efficacy Without Affecting Drug Stability: Insights into Photosensitizer–Antibiotic Combination Therapies
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311267 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Rocío B Acosta und 2 weiteren Autor:innen. Beteiligte Einrichtung: IDAS-CONICET, Departamento de Química, Facultad de Ciencias Exactas, Físico-Químicas y Naturales, Universidad Nacional de Río Cuarto, Ruta Nacional 3…. Hauptthemen laut MEDLINE: Photosensitizing Agents, Anti-Bacterial Agents, Photochemotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Investigaciones Científicas y Técnicas, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) of Argentina.
Abstract (Originalsprache)
Photodynamic inactivation (PDI) represents a promising strategy to overcome bacterial resistance by combining light, oxygen, and a photosensitizer (PS) to generate reactive oxygen species (ROS) that damage essential cellular components. Combining PDI with conventional antibiotics (ATBs) may further enhance bacterial eradication through complementary mechanisms. In this study, the tetracationic 5,10,15,20-tetra(4-N,N,N-trimethylammoniophenyl)porphyrin (TMAP4+) was evaluated in combination with ATBs: ampicillin (AMP) and rifampicin (RIF) against Staphylococcus aureus and cephalexin (CFX) against Escherichia coli. The photostability of all agents was assessed under the experimental irradiation conditions, and no evidence of physical interaction between TMAP4+ and the ATBs was detected. AMP and CFX remained photostable, while RIF exhibited only minimal photodegradation under white light, confirming its stability during PDI treatments. The antimicrobial assays revealed that irradiation significantly enhanced the bactericidal activity of TMAP4+. When combined with ATBs, photoactivated TMAP4+ led to a pronounced reduction in the minimum inhibitory concentration (MIC) values of AMP and RIF for S. aureus and of CFX for E. coli, indicating additive effects. Growth curve analyses corroborated these results, showing delayed bacterial growth and decreased maximal optical densities in the combined treatments compared to single agents. Overall, these findings demonstrate that the photodynamic process can potentiate the antimicrobial effect of conventional ATBs without compromising their stability, supporting the potential of PS–ATB combination therapies as a valuable approach to improve antibacterial efficacy and mitigate ATB resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IDAS-CONICET, Departamento de Química, Facultad de Ciencias Exactas, Físico-Químicas y Naturales, Universidad Nacional de Río Cuarto, Ruta Nacional 36 Km 601, Río Cuarto X5804BYA, Córdoba, Argentina.
ORCID-Profile: Edgardo N Durantini, Mariana B Spesia
Förderung
- Consejo Nacional de Investigaciones Científicas y Técnicas
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) of Argentina
Zitieren
APA
Acosta, R. B., Durantini, E. N., & Spesia, M. B. (2025). Photodynamic Inactivation Enhances Antibiotic Efficacy Without Affecting Drug Stability: Insights into Photosensitizer–Antibiotic Combination Therapies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311267
Vancouver
Acosta RB, Durantini EN, Spesia MB. Photodynamic Inactivation Enhances Antibiotic Efficacy Without Affecting Drug Stability: Insights into Photosensitizer–Antibiotic Combination Therapies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311267
BibTeX
@article{Acosta2025,
author = {Acosta, Rocío B and Durantini, Edgardo N and Spesia, Mariana B},
title = {Photodynamic Inactivation Enhances Antibiotic Efficacy Without Affecting Drug Stability: Insights into Photosensitizer–Antibiotic Combination Therapies},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311267}
}
EUVIMED